MLICM
ACH

Metropolitan Life Insurance Company (MetLife)’s Accendra Health ACH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,950
Closed -$109K – 1464
2024
Q1 		$109K Sell
3,950
-414
-9% -$9.19K ﹤0.01% 1004
2023
Q4 		$84.1K Hold
4,364
– – ﹤0.01% 1180
2023
Q3 		$70.5K Buy
4,364
+370
+9% +$6.57K ﹤0.01% 1204
2023
Q2 		$76K Hold
3,994
– – ﹤0.01% 1171
2023
Q1 		$58.1K Sell
3,994
-460
-10% -$8.24K ﹤0.01% 1305
2022
Q4 		$87K Hold
4,454
– – ﹤0.01% 1131
2022
Q3 		$107K Hold
4,454
– – 0.01% 976
2022
Q2 		$140K Hold
4,454
– – 0.01% 878
2022
Q1 		$196K Sell
4,454
-14,895
-77% -$640K 0.01% 826
2021
Q4 		$842K Hold
19,349
– – 0.01% 1087
2021
Q3 		$605K Sell
19,349
-1,837
-9% -$72.3K 0.01% 1324
2021
Q2 		$897K Buy
21,186
+1,300
+7% +$50.6K 0.01% 1098
2021
Q1 		$748K Sell
19,886
-568
-3% -$17.8K 0.01% 1150
2020
Q4 		$553K Buy
20,454
+150
+0.7% +$3.86K 0.01% 1289
2020
Q3 		$510K Hold
20,304
– – 0.01% 1208
2020
Q2 		$155K Hold
20,304
– – ﹤0.01% 1984
2020
Q1 		$186K Buy
20,304
+11,646
+135% +$70.3K ﹤0.01% 1632
2019
Q4 		$44.8K Sell
8,658
-13,617
-61% -$87.4K ﹤0.01% 2498
2019
Q3 		$129K Buy
22,275
+5,524
+33% +$24.8K ﹤0.01% 2158
2019
Q2 		$53.6K Hold
16,751
– – ﹤0.01% 2499
2019
Q1 		$68.7K Sell
16,751
-3,216
-16% -$20.3K ﹤0.01% 2484
2018
Q4 		$126K Hold
19,967
– – ﹤0.01% 2121
2018
Q3 		$330K Hold
19,967
– – 0.01% 1658
2018
Q2 		$334K Hold
19,967
– – 0.01% 1581
2018
Q1 		$310K Sell
19,967
-15,307
-43% -$273K ﹤0.01% 1596
2017
Q4 		$666K Sell
35,274
-61,256
-63% -$1.36M 0.01% 1090
2017
Q3 		$2.82M Sell
96,530
-694
-0.7% -$20.5K 0.02% 832
2017
Q2 		$3.13M Sell
97,224
-101
-0.1% -$3.31K 0.02% 809
2017
Q1 		$3.37M Sell
97,325
-3,336
-3% -$119K 0.02% 778
2016
Q4 		$3.55M Sell
100,661
-1,801
-2% -$60.9K 0.03% 742
2016
Q3 		$3.56M Sell
102,462
-422
-0.4% -$14.8K 0.03% 724
2016
Q2 		$3.85M Buy
102,884
+2,143
+2% +$80.5K 0.03% 661
2016
Q1 		$4.07M Buy
100,741
+1,196
+1% +$44.5K 0.03% 612
2015
Q4 		$3.58M Buy
99,545
+2,508
+3% +$90.7K 0.03% 650
2015
Q3 		$3.1M Sell
97,037
-3,727
-4% -$127K 0.02% 721
2015
Q2 		$3.43M Sell
100,764
-1,997
-2% -$67.3K 0.02% 736
2015
Q1 		$3.48M Buy
102,761
+1,909
+2% +$66.5K 0.03% 684
2014
Q4 		$3.54M Buy
100,852
+477
+0.5% +$16.1K 0.02% 709
2014
Q3 		$3.29M Buy
100,375
+54
+0.1% +$1.84K 0.02% 713
2014
Q2 		$3.41M Sell
100,321
-1,194
-1% -$40.9K 0.02% 742
2014
Q1 		$3.56M Buy
101,515
+982
+1% +$34.6K 0.02% 711
2013
Q4 		$3.67M Buy
100,533
+1,172
+1% +$43K 0.03% 671
2013
Q3 		$3.44M Sell
99,361
-557
-0.6% -$19.5K 0.03% 653
2013
Q2 		$3.38M Buy
+99,918
New +$3.32M 0.03% 628

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ACH Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Accendra Health (ACH) in Q2 2024, closing a stake of 3,950 shares — an estimated $109K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACH in Q2 2013 and held it in 44 quarters. The position peaked at $4.07M in Q1 2016. 221 funds tracked by Wall St. Rank hold ACH as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Accendra Health position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,950 Accendra Health shares in Q2 2024, an estimated $109K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Accendra Health in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Accendra Health position peaked at $4.07M in Q1 2016.
  • 221 funds tracked by Wall St. Rank held Accendra Health as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.